organic solvent (ethyl acetate or dichloromethane) and the continuous phase was 5 wt% aqueous poly(vinyl alcohol) solution. The droplets with a coefficient of variation in dripping regime below 2.5 % were evaporated to form polymeric particles with uniform sizes ranging between 4-30 µm. The particle microstructure and surface roughness were modified by adding nanofiller (montmorillonite nanoclay) or porogen (2-methylpentane) in the dispersed phase to form less porous polymer matrix or porous particles with golf-ball-like dimpled surface, respectively. The presence of 2-4 wt% nanoclay in the host polymer significantly reduced the release rate of paracetamol and prevented the early burst release, as a result of reduced polymer porosity and tortuous path for the diffusing drug molecules. Numerical modelling results using the volume of fluid-continuum surface force model agreed well with experimental behaviour and revealed trapping of nanoclay particles in the dispersed phase upstream of the orifice at low dispersed phase flow rates and for 4 wt% nanoclay content, due to vortex formation. Janus PLA/PCL (polycaprolactone) particles were produced by solvent evaporation-induced phase separation within organic phase droplets containing 3 % (v/v)
INTRODUCTION
Conventional oral and intravenous drug administration routes are characterized by rapid drug release and absorption. 1 Limitations such as poor patient compliance (due to missing or altering dosages) and difficulty in attainment of steady state conditions (as a result of peakvalley plasma concentration fluctuations) have led to poor drug efficacy and toxicity as consequences of underdosing and overdosing of drugs respectively in patients. 2 Drug delivery systems have been designed to overcome these limitations and extend, delay and target drug release [3] [4] [5] [6] . When properly designed, controlled drug delivery systems should be able to deliver drugs at a predetermined rate and manner, either locally or systemically, for a specific period of time after drug administration, which can eliminate excessive fluctuations of drug plasma concentrations. 7 Biocompatible polymeric materials such as non-biodegradable hydrophobic polymers, 8 hydrogels, 9 water soluble polymers, 10 and synthetic biodegradable polymers have been widely used as vehicles for drug delivery. 1 Biodegradable polymers have been mainly used in the form of microspheres, since they offer high surface area for adhesion and drug release and a low drag force during mobility in fluids. 11 The most common biodegradable synthetic polymers are poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA) 12 , and polycaprolactone (PCL), 1, 13 due to their approval by FDA (Food and Drug Administration) 14 and environmentally friendly nature. In order to meet different dosage requirements, there is a strong need to modify drug solubility and release rate by incorporation of different additives into a host biodegradable polymer.
Nanoclays are FDA approved plate-like nanoparticles of layered mineral silicates that can be integrated into the polymer matrix to improve mechanical and rheological properties of polymeric microspheres and increase the solubility and bioavailability of drugs such as ibuprofen, indomethacin, diclofenac, naproxen, fenbufen, and paracetamol. 2 Nanoclays also have highly desirable dietary, bacterial and metabolic detoxification characteristics 15 .
Another method of modification of drug release kinetics is internal phase separation caused by addition of non-solvent in the mixture of polymer and solvent prior to emulsification.
Depending on polymer to non-solvent ratio and the type of solvent, non-solvent and polymer, phase separation within emulsion droplets (triggered by solvent evaporation) can lead to core/shell, occluded, acorn or heteroaggregated particle morphology. 16 Hole-shell and crescent-moon-shaped microparticles can be synthesised from acorn-shaped biphasic droplets by polymerisation of one of the phases. 17, 18 Such unique morphologies can modify drug release profile 12, 19, 20 and increase the potential for alternative routes of drug administration.
Emulsion-solvent evaporation is one of the most common methods for fabrication of polymeric microspheres from pre-formed polymers. Emulsification can be carried out using conventional top-down methods based on breaking larger droplets into smaller ones, 21 such as mechanical agitation, high-pressure homogenization, and sonication or bottom-up methods, based on direct drop-by-drop generation, such as membrane emulsification [22] [23] [24] , microchannel emulsification, 25 and microfluidic techniques. [26] [27] [28] [29] Conventional emulsification methods are energy intensive and often lead to polydispersed microspheres. Microfluidic methods allow production of particles with low polydispersity (CV = Standard Deviation/Mean < 3%) and high encapsulation efficiency that are perfectly tailored to meet the needs of pharmaceutical industry. 30 However, microfluidic droplet generators are typically planar (2-D) and made from single crystal silicon chips using expensive microfabrication methods 31 or mouldable polymers such as polydimethylsiloxane (PDMS), which swell and deform in contact with organic solvents. 29 Here, we investigate formation of structured polymeric microspheres using glass capillary microfluidic devices. These devices pioneered by Utada et al. 32 offer 3-D flow focusing that minimizes wetting, they are cheap to fabricate and more mechanically robust and inert than polymeric devices. 33, 13 Microstructural modifications of polymer matrix occurred due to introduction of nanoclay, non-solvent or second polymer, which resulted in the formation of composite and non-spherical particles and particles with structured surface (Figure 1b-d) . Figure 1 . Strategies used in this work for creation of polymer particles: (a) Plain polymer particle; (b) Nanoclay embedded polymer particle; (c) Golf ball-like particle; (d) Janus and hemispherical particle. A special attention was paid on the effect of flow conditions on the retention (trapping) of suspended nanoparticles in the device. This phenomenon is important in all microfluidic processes where fluid streams entering a microfluidic channel contain suspended nanoobjects, such as colloidal particles, nano-assemblies, nanofibers, nanotubes or viruses. The effect of internal structure of the particles on the release rate of encapsulated drug was also discussed. Glass capillary devices have been used for fabrication of vesicles such as colloidosomes 34 , polymersomes, 35 and liposomes, 36 and microparticles such as solid lipid 37 and microgel 33 particles.
This paper presents new applications of glass capillary microfluidics for the production of drug delivery vehicles composed of nanoclay-embedded, golf ball-like, Janus, and hemispherical polymeric particles. A facile control over the particle size and morphology achieved in this work enables accurate prediction of drug release behavior. For droplet production, glass capillary device was placed on a GXM XD63 optical inverted microscope. The dispersed and continuous phase of desired formulation (Table 1) water is 10.7 and 17.4 g/kg, respectively. 38 The cumulative release was determined by:
EXPERIMENTAL SECTION

Materials
where is the concentration of drug in the continuous phase and 0 is the predicted drug concentration in the continuous phase after complete release.
Governing Equations and Numerical Modelling. Numerical modelling of drop generation was
carried out using a two-dimensional axisymmetric volume of fluid (VOF) approach. 39 The following equations of mass, Eq. 2, and momentum conservation, Eq. 3, were used:
where � �⃗ and P are velocity and pressure and t, , and are time, dynamic viscosity and density. The interfacial force, , and gravitational force are included in the source term, ,
However, since the length-scale is in the order of micro, the gravitational force is negligible and ����⃗ = ���⃗ . In VOF model, a momentum equation is solved for all phases and the advection of interface is tracked by solving a transport equation for volume fraction, :
where f determines the portion of each cell filled with one of the two phases: f = 0 the cell is filled with aqueous phase 0 < f < 1 fluid-fluid interface exists in the cell (5) f = 1 the cell is filled with oil phase
The dynamic viscosity and density in the momentum equation, Eq. 3, were calculated by:
where the subscripts o and w refer to oil and aqueous phases respectively. Continuum surface force (CSF) method 40 was used to calculate the interfacial force term included in Eq. 3:
where γ is the interfacial tension and κ the local curvature of the interface, calculated as:
where n � is the unit normal defined as: approximated by second order upwind scheme and the pressure term was interpolated using PRESTO scheme. The exact pressure was calculated on the cell faces in order to prevent interpolation error. The pressure-velocity coupling was achieved by SIMPLE scheme and the interpolation of interface was performed by Geo-Reconstruct algorithm. In order to reduce the computational cost, a variable time step method was used with Co = 0.35. A grid independence study was carried out by generating four meshes with resolutions of 8, 6, 4, and 2 µm. Since the solutions for 4 and 2 µm were very similar, the resolution of 4 µm was selected for the simulations. A summary of the boundary conditions is listed in Table 2 . Table 3 . found earlier for the dispersed phase composed of PLA in DCM, 41 which means that the presence of nanoclay in DCM did not affect droplet generation. Droplet formation is a result of the balance between the detaching forces acting in the direction of flow (viscous drag and inertial force) and the interfacial tension force acting in the opposite direction. In dripping regime, which occurs at low flow rates of both phases, the main competition is between drag and interfacial tension force. A viscous drag force increases with increasing / , as a result of increase in the velocity gradient at the interface, causing the growing droplet to detach more quickly, which leads to smaller droplets and faster droplet generation (Figure 3 ).
The ratio between viscous drag force exerted on the interface by the continuous phase and interfacial tension force is represented by the Capillary number of the continuous phase, ,
given by ⁄ , which is ranges between 0.003 and 0.006 for the conditions shown in Figure 3 .
The results in Figure 3 were obtained in dripping regime, which occurs at 3 < / < 30, but must be within a certain range. If is too low, droplet generation is unstable or nonexisting, irrespective of / value. If is too high, transition from dripping to widening jetting occurs and the droplet size is a result of the competition between inertial force of the dispersed phase and interfacial tension. The Weber number of the dispersed phase is the ratio between the inertial force of the dispersed phase and interfacial tension, :
where is the dispersed phase density, is the jet diameter, and is the mean velocity of the dispersed phase. For the data shown in Figure 3 , = 0.002-0.02.
At / > 30, the dispersed phase forms a long narrow jet that breaks into polydispersed droplets further downstream (Figure 2d ), which is known as the narrowing jetting regime. 33 In contrast, dripping regime is characterised by highly uniform droplets with < 3% (Figs. 2 b and c). In Figure 3 , ranged from 0.8 to 2.5% for = 200 µm and similar s were obtained in dripping regime for other orifice sizes and emulsion formulations.
As shown in Figure 3 for the dispersed phase containing DCM, progressively smaller droplets were generated when the orifice diameter was reduced from 224 to 100 µm. This effect is illustrated for ethyl acetate on the images shown in Figure 4 , where the orifice diameters of 200, 110, 70, and 40 µm resulted in the droplet diameters of 149, 69, 47, and 27 µm respectively. In each case, droplets were smaller than their orifices preventing surface wetting. To generate droplets in dripping regime, / was 3.6-12.5 and was gradually reduced with reducing orifice size to prevent too high velocity of the dispersed phase at the orifice that would cause transition from dripping to widening jetting. Vorticity is the measure of a fluid element rotation as it moves in flow field, and is defined as the curl of velocity vector: ξ = ∇ × U � �⃗ . Therefore, the vorticity magnitude |ξ|, is the magnitude of velocity vector curl, �∇ × U � �⃗ �. 44 At low dispersed phase flow rate of = 0.2 ml h -1 ( Figure   5 .a3 and b3), a very strong vortex flow forms in front of the orifice, which prevents the entrance of nanoparticles through the orifice. By increasing from 0.2 to 0.5 to 3 ml h -1 , the vortex flow strength decreases, which results in a reduction of vorticity magnitude and suppression of the filtration effect, so that progressively higher proportion of nanoparticles can pass through the orifice. The presence of strong vortex flow at low is a consequence of the high velocity gradient at the liquid-liquid interface. As increases, the velocity gradient is reduced causing the vortices to weaken. The particles closer to interface can enter the orifice easier than the particles further away from the interface. It can be explained by a higher level of shearing in the interfacial region than in the bulk of the dispersed phase flow.
Movies (2-4) in supporting information show this phenomenon.
A particle trapping phenomenon shown in Figure 5 can be used to achieve a continuous passive separation of nanoparticles from fluid streams. It differs from inertial particle separation in a Vortex Chip consisted of multiple expansion-contraction reservoirs, 45, 46 as hydrodynamic flow focusing does not require a prior stage of particle alignment by inertial focusing. A passive separation of nanoparticles by microfluidic flow focusing has the advantage over traditional filtration of exploiting orifice which is significantly larger than the particles and therefore, not prone to clogging. It eliminates the need for frequent backwashing and maintenance shutdowns which are common in filtration processes.
Particle production from emulsions. As predicted by Eq. (12), is directly proportional to for all formulations, with small deviations between the experimental and theoretical results for both polymers and solvents (DCM and EA). Figure 7 reflects the ability of the process to precisely tune the particle size over a wide range of 4-30 µm, whilst maintaining high particle size uniformity. Particles that are 4 µm are considered suitable for intravenous drug administration since the smallest capillary blood vessels have a diameter of about 7 µm. 47 Particles in the size range of µm are suitable for parenteral drug delivery via subcutaneous or intramuscular injection. 48 As expected, the particle size increased with increasing the polymer concentration , which can be seen in Figure 7 (a) for PLGA particles at = 0.5-2 wt%. Under the same conditions, PLGA particles are smaller than PLA particles (Figures 7 (a) and (b) for 1 wt% polymer in EA), since particle diameters are inversely proportional to the cubed root of particle densities and the density of PLGA (1.34 g cm -3 ) is higher than that of PLA (1.24 g cm -3 ). The effect of solvent type on the particle size can be seen in Figure 7 (b), which compares the size of PLA particles produced using the same polymer concentration in the dispersed phase (1 wt%), but different solvents (EA and DCM). Smaller particles were produced using EA, due to the lower density of EA (0.902 g cm -3 ) as compared to DCM (1.33 g cm -3 ).
In Figure 7 , a minor deviation between experimental particle sizes and their theoretical estimates is a result of pore formation in the polymer matrix, which was not accounted for in the material balance equation (Eq. 11). The particle porosity can be estimated from the ratio of the gradients of the theoretical and experimental vs. lines:
Solvent choice can also affect the porosity of particles, as can be seen in Figure 7 (b). The porosity of PLA particles produced using DCM and EA was 14.8 and 25.5 % respectively, estimated from Eq. (13). At 20 °C, water is more soluble in EA (3.3 wt%) than in DCM (0.24 wt%). 49 The higher the solubility of water in the organic phase, the higher the amount of water taken up by the droplets and the higher the porosity of the particles after solvent evaporation, which is similar to the effect of internal water in W/O/W emulsion. 13 Therefore, apart from phase flow rates and polymer concentration, densities of the polymer and solvent and water solubility in the organic phase also play a significant role in the control of particle size and porosity.
Nanoclay-Embedded Polymer Particles. Figure 8 shows the effect of nanoclay on the particle size for the dispersed phase containing PLA in DCM (red symbols) and PLGA in EA (black symbols). The solid lines are the trend lines for nanoclay embedded particles, the dashed lines are the trend lines for plain polymeric particles, while the dotted lines satisfy Eq. (12). For PLA in DCM, the vs. lines have higher gradients, due to higher density of DCM compared to EA. In the absence of swelling effects and particle porosity, all lines for the same polymer and solvent should coincide, irrespective of the presence of nanoclay (due to small amount of nanonclay in the polymer matrix), which is not the case in Figure 8 . A higher deviation of experimental particle diameters from their values predicted by Eq. (12) was observed for both nanoclay embedded polymers, as compared to plain particles. It can be explained by either higher porosity or higher degree of swelling of nanoclay-loaded particles compared to plain polymer particles. Figure 9 . FIB cross-sections of: (a) PLA particle showing pores in the polymer network; (b) nanoclay embedded PLA particles with non-porous internal structure. Scale Bars: 5 µm.
FIB cross-sectioned images of PLA particles shown in Figure 9 indicate that nanoclayembedded PLA particles are significantly less porous than those produced without nanoclay.
When placed in contact with water, montmorillonite can adsorb up to 10 g H 2 O/g clay, which
can increase its volume by up to 20 times 50 . The exact degree of swelling depends on the type of exchangeable cation. Although montmorillonites cation-exchanged with quaternary ammonium cations are primarily swollen by organic solvents, they can adsorb up to 400 mg H 2 O/g clay. 51 This water uptake increases the size of the particles and makes the polymer matrix more compact and less permeable to gases. 52 Hence, a compact structure of nanoclay/PLA particle in Figure 9b is an evidence of the presence of nanoclay in the polymer matrix and the XRD plot shown in Figure 10 provides another evidence. Figure 10 . XRD plot of nanoclay powder, PLA/nanoclay particles and plain PLA particles.
The amorphous nature of pure poly(DL-lactic acid) is confirmed in Figure 10 by a broad amorphous 'hump' over a wide 2Ө range of 10-30°, due to X-rays being scattered in many directions. In contrast, high intensity narrower peaks were observed in the XRD pattern of pure crystalline nanoclay powder. Nanoclay embedded polymer particles exhibit crystal peaks at similar positions as pure nanoclay (2Ө=5°, 20°, 30° and 35°), in addition to a wide hump part, which serves as an evidence of the embedment of nanoclay in the polymer matrix. brings about dimples, which are 'footprints' formed by droplets of the non-solvent on the surface of the PLA particle. Also, pores can be seen in the FIB cross section shown in Figure   11 (d), which are the result of phase separation between the polymer and the non-solvent.
However, when the same emulsion was produced with gentle stirring in the collection vial, smaller dimples were formed on the surface of particles as shown in Figure 11 (e) and (f). In this case, the droplets of the non-solvent detach earlier from the surface, thereby, inducing formation of smaller dimples on the surface. Pores are also noticeable in the particle cross section created by FIB (Figure 11g ), since stirring does not affect the migration rate of inner droplets to the surface but only the rate of their detachment from the particle surface. shown in Figure 11 (h) and (i). Higher particle porosity in Figure 11 (i) can be attributed to the higher percent of non-solvent in the dispersed phase, as compared to that in Figure 11 (a-g) .
Therefore, the variation in the amount of polymer and non-solvent could serve as a means of adjusting particle porosity and surface roughness. Surface dimples can act as picoliter beakers, 11 but can also enhance cell adhesion 53 and particle mobility and dispersibility in fluids, due to Magnus effect and minimised contact area. It is important if the fabricated particles are intended to be used as carriers in dry powder inhaler formulations. Furthermore, the amount of drug released after 1 h from plain 25-µm PLA particles ( Figure   12c ) was lower than that from plain 45-µm PLGA particles (Figures 12b) , although in the former case both the initial polymer concentration in the dispersed phase and the particle size was lower. It is expected because PLGA typically exhibits a faster degradation than PLA. 49 PLA is more hydrophobic than PLGA due to extra methyl groups in glycolide residues and the ester bonds of PLA are less prone to hydrolysis due to steric hindrance. Furthermore, PLGA 50:50 used in this work has the fastest degradation rate among all PLGA copolymers. Figure 10c shows that the drug release rate from golf-ball-shaped PLA particles was higher than that from plain PLA particles of the same size, which can be attributed to the higher porosity of dimpled particles, due to the presence of non-solvent in the dispersed phase. More porous polymer matrix makes it easier for water molecules to penetrate inside the particles, which results in faster polymer degradation and drug release.
The release rate of paracetamol in Fig. 12 is very high as a result of the high solubility of paracetamol in water (17.4 g/kg) and high solubility of ethyl acetate in water (8.3 %).
Irrespective of the fast release profiles, the rate of drug release was precisely controlled by the microstructure of the particles. Figures 13 (b) and (e), bright green regions occupy respectively 1/3 and 2/3 of the total particle area, corresponding to the proportion of PLA in the polymer mixture. It shows that phase separation within the droplets was complete with only trace amounts of PLA present in PCL portions and vice versa. Nile red binds nonspecifically to both polymers, resulting in red fluorescence of entire Janus particle ( Figure 13 c and f). However, PLA portions exhibit a brighter shade of red, due to contribution from both Nile red and Rh6G to the total light emission. The preferential sorption observed here for the model drug Rh6G could be utilized for controlled drug loading as proportions of constituent polymers in the formulation can be varied in a controlled fashion. Also, coencapsulation of drugs could be possible since a second drug with high affinity for PCL could be introduced to effect simultaneous controlled release of two drugs. The release pattern can be controlled by the rate of degradation of the constituent polymers. The degradation properties could be harnessed to achieve multiple site drug delivery, e.g. particles produced from combination of a low and high pH soluble polymer would deliver drugs to gastric and enteric regions respectively from a single dose. Consequently, the dissolved polymer which can be recovered and reused, acts as a size and shape adjustment tool. The unique morphology of Janus and hemispherical particles can also be exploited for unique release properties when these particles are used as drug vehicles. 
Janus and Hemispherical Polymer
CONCLUSIONS
Synthetic polymer biodegradable microparticles with tunable size, shape, internal structure and surface roughness were produced by counter-current flow focusing in 3-D glass capillary devices. The microstructure of the particles was tailored by the addition of nanoclay, polymer non-solvent (porogen) or a second polymer in the dispersed phase prior to emulsification. The polymer matrix was found to be less porous or more porous as a result of the addition of nanoclay or 2-methylpentane, respectively, which proved to have profound effects on the release rate of paracetamol. Surface dimples which can enhance particle mobility in air and cell adhesion properties were created by adding 2-methylpentane to the dispersed phase. The size and shape of the dimples and the particle porosity were adjusted by the rate of stirring in the collection vial and the concentration of non-solvent and polymer in the dispersed phase.
Numerical modelling of fluid flow for nanoclay-loaded droplets revealed the trapping of nanoparticles in the dispersed phase at low flow rates due to vortex formation upstream of the orifice. The phenomenon of microvortex-based particle trapping can be exploited for passive separation of nanoparticles from fluid streams.
Janus PLA/PCL particles were produced by emulsifying PLA/PCL blends (30/70 or 70/30) dissolved in dichloromethane and subsequent internal phase separation induced by solvent evaporation. A strong preferential sorption of Rhodamine 6G fluorescence dye onto PLA was successfully utilized to identify PLA portions of the Janus particles by CLSM. This could be exploited for modified drug release by polymer content variation, drug co-encapsulation and multiple site drug delivery. Uniform hemispherical PCL particles were obtained by dissolution of PLA domes with acetone. The dissolved polymer, which can be recovered and reused, acts as a size and shape adjustment tool and the increased surface area and nonspherical shape can be exploited for unique drug release properties.
Glass capillary devices were found to be extremely useful tool for preparation of polymeric microspheres with versatile morphology and structure. The particle size can easily be 
